260 related articles for article (PubMed ID: 25571972)
41. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury.
Chen Y; Qian H; Zhu W; Zhang X; Yan Y; Ye S; Peng X; Li W; Xu W
Stem Cells Dev; 2011 Jan; 20(1):103-13. PubMed ID: 20446811
[TBL] [Abstract][Full Text] [Related]
42. Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling.
Herzog C; Lorenz A; Gillmann HJ; Chowdhury A; Larmann J; Harendza T; Echtermeyer F; Müller M; Schmitz M; Stypmann J; Seidler DG; Damm M; Stehr SN; Koch T; Wollert KC; Conway EM; Theilmeier G
Cardiovasc Res; 2014 Mar; 101(3):400-10. PubMed ID: 24323314
[TBL] [Abstract][Full Text] [Related]
43. HMGB1: a signal of necrosis.
Raucci A; Palumbo R; Bianchi ME
Autoimmunity; 2007 Jun; 40(4):285-9. PubMed ID: 17516211
[TBL] [Abstract][Full Text] [Related]
44. HMGB1 release in co-cultures of porcine endothelial and human T cells.
Kawahara K; Setoyama K; Kikuchi K; Biswas KK; Kamimura R; Iwata M; Ito T; Morimoto Y; Hashiguchi T; Takao S; Maruyama I
Xenotransplantation; 2007 Nov; 14(6):636-41. PubMed ID: 17991152
[TBL] [Abstract][Full Text] [Related]
45. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
46. Role of cell-cell interactions in high mobility group box 1 cytokine activity in human peripheral blood mononuclear cells and mouse splenocytes.
Kohka Takahashi H; Sadamori H; Liu K; Wake H; Mori S; Yoshino T; Yamamoto Y; Yamamoto H; Nishibori M
Eur J Pharmacol; 2013 Feb; 701(1-3):194-202. PubMed ID: 23228930
[TBL] [Abstract][Full Text] [Related]
47. At the crossroads of necrosis and apoptosis: signaling to multiple cellular targets by HMGB1.
Bustin M
Sci STKE; 2002 Sep; 2002(151):pe39. PubMed ID: 12297673
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic effects of hepatocyte growth factor-overexpressing human umbilical cord blood-derived mesenchymal stem cells on liver fibrosis in rats.
Seo KW; Sohn SY; Bhang DH; Nam MJ; Lee HW; Youn HY
Cell Biol Int; 2014 Jan; 38(1):106-16. PubMed ID: 24115681
[TBL] [Abstract][Full Text] [Related]
49. During apoptosis HMGB1 is translocated into apoptotic cell-derived membranous vesicles.
Schiller M; Heyder P; Ziegler S; Niessen A; Claßen L; Lauffer A; Lorenz HM
Autoimmunity; 2013 Aug; 46(5):342-6. PubMed ID: 23194089
[TBL] [Abstract][Full Text] [Related]
50. The secretion of HMGB1 is required for the migration of maturing dendritic cells.
Dumitriu IE; Bianchi ME; Bacci M; Manfredi AA; Rovere-Querini P
J Leukoc Biol; 2007 Jan; 81(1):84-91. PubMed ID: 17035340
[TBL] [Abstract][Full Text] [Related]
51. Expression of high mobility group box 1 in inflamed dental pulp and its chemotactic effect on dental pulp cells.
Zhang X; Jiang H; Gong Q; Fan C; Huang Y; Ling J
Biochem Biophys Res Commun; 2014 Aug; 450(4):1547-52. PubMed ID: 25019990
[TBL] [Abstract][Full Text] [Related]
52. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
[TBL] [Abstract][Full Text] [Related]
53. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1.
DeMarco RA; Fink MP; Lotze MT
Mol Immunol; 2005 Feb; 42(4):433-44. PubMed ID: 15607795
[TBL] [Abstract][Full Text] [Related]
54. Ethyl pyruvate induces necrosis-to-apoptosis switch and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells.
Lim SC; Choi JE; Kim CH; Duong HQ; Jeong GA; Kang HS; Han SI
Int J Mol Med; 2007 Aug; 20(2):187-92. PubMed ID: 17611636
[TBL] [Abstract][Full Text] [Related]
55. [The role and mechanism of mesenchymal stem cell in modulating human pulmonary microvascule endothelial cell permeability via paracrine hepatocyte growth factor].
Chen QH; Zheng RQ; Wang HL; Yang Y; Qiu HB
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Nov; 40(11):855-858. PubMed ID: 29320834
[No Abstract] [Full Text] [Related]
56. Liver Anti-Fibrosis Therapy with Mesenchymal Stem Cells Secreting Hepatocyte Growth Factor.
Ishikawa H; Jo J; Tabata Y
J Biomater Sci Polym Ed; 2012; 23(18):2259-72. PubMed ID: 22182291
[TBL] [Abstract][Full Text] [Related]
57. Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material.
Lotfi R; Eisenbacher J; Solgi G; Fuchs K; Yildiz T; Nienhaus C; Rojewski MT; Schrezenmeier H
Eur J Immunol; 2011 Jul; 41(7):2021-8. PubMed ID: 21538978
[TBL] [Abstract][Full Text] [Related]
58. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation.
Lutz W; Stetkiewicz J
Int J Occup Med Environ Health; 2004; 17(2):245-54. PubMed ID: 15387080
[TBL] [Abstract][Full Text] [Related]
59. Human mesenchymal stromal cells exert HGF dependent cytoprotective effects in a human relevant pre-clinical model of COPD.
Kennelly H; Mahon BP; English K
Sci Rep; 2016 Dec; 6():38207. PubMed ID: 27922052
[TBL] [Abstract][Full Text] [Related]
60. Dual faced HMGB1 plays multiple roles in cardiomyocyte senescence and cardiac inflammatory injury.
Lu H; Zhang Z; Barnie PA; Su Z
Cytokine Growth Factor Rev; 2019 Jun; 47():74-82. PubMed ID: 31129019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
